Identification of CX3CR1 -: A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1

被引:247
|
作者
Combadiere, C
Salzwedel, K
Smith, ED
Tiffany, HL
Berger, EA
Murphy, PM
机构
[1] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA
[3] CHU X Bichat, INSERM U479, F-75877 Paris, France
关键词
D O I
10.1074/jbc.273.37.23799
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fractalkine is a multimodular human leukocyte chemoattractant protein and a member of the chemokine superfamily. Unlike other human chemokines, the chemokine domain of fractalkine has three amino acids between two conserved cysteines, referred to as the CX3C motif. Both plasma membrane-associated and shed forms of fractalkine have been identified. Here, we show that the recombinant 76-amino acid chemokine domain of fractalkine is a potent and highly specific chemotactic agonist at a human orphan receptor previously named V28 or alternatively CMKBRL1 (chemokine beta receptor-like 1), which was shown previously to be expressed in neutrophils, monocytes, T lymphocytes, and several solid organs, including brain. CMKBRL1/V28 also functioned with CD4 as a coreceptor for the envelope protein from a primary isolate of HIV-1 in a cell-cell fusion assay, and fusion was potently and specifically inhibited by fractalkine. Thus CMKBRL1/V28 is a specific receptor for fractalkine, and we propose to rename it CX(3)CR1 (CX3C chemokine receptor 1), according to an accepted nomenclature system.
引用
收藏
页码:23799 / 23804
页数:6
相关论文
共 50 条
  • [31] Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease
    Patel, A.
    Jagadesham, V. P.
    Porter, K. E.
    Scott, D. J. A.
    Carding, S. R.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2008, 36 (01) : 20 - 27
  • [32] Expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the trigeminal ganglia: implications for craniofacial nociception
    Gazerani, P.
    Cairns, B. E.
    Dong, X. D.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [33] Association of Common Polymorphisms in the Fractalkine Receptor (CX3CR1) With Obesity
    Sirois-Gagnon, Dave
    Chamberland, Annie
    Perron, Stephanie
    Brisson, Diane
    Gaudet, Daniel
    Laprise, Catherine
    OBESITY, 2011, 19 (01) : 222 - 227
  • [34] Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis
    G Celesti
    G Di Caro
    P Bianchi
    F Grizzi
    F Marchesi
    G Basso
    D Rahal
    G Delconte
    M Catalano
    P Cappello
    M Roncalli
    A Zerbi
    M Montorsi
    F Novelli
    A Mantovani
    P Allavena
    A Malesci
    L Laghi
    British Journal of Cancer, 2013, 109 : 2424 - 2433
  • [35] Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue
    Hosokawa, Y
    Nakanishi, T
    Yamaguchi, D
    Nakae, H
    Matsuo, T
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 139 (03): : 506 - 512
  • [36] Expression and Function of the Chemokine CX3CL1 and Its Receptor Cx3cr1 in Human Colorectal Cancer
    Erreni, Marco
    Laghi, Luigi
    Celesti, Giuseppe
    Bianchi, Paolo
    Grizzi, Fabio
    Solinas, Graziella
    Pesce, Samantha
    Malesci, Alberto
    Mantovani, Alberto
    Allavena, Paola
    GASTROENTEROLOGY, 2010, 138 (05) : S736 - S736
  • [37] Chemokine CX3CL1 and its receptor CX3CR1 are associated with human atherosclerotic lesion volnerability
    Zhang, Xiaolin
    Feng, Xueyao
    Cai, Wenzhi
    Liu, Tengfei
    Liang, Zhenyang
    Sun, Ying
    Yan, Chenghui
    Han, Yaling
    THROMBOSIS RESEARCH, 2015, 135 (06) : 1147 - 1153
  • [38] Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis
    Celesti, G.
    Di Caro, G.
    Bianchi, P.
    Grizzi, F.
    Marchesi, F.
    Basso, G.
    Rahal, D.
    Delconte, G.
    Catalano, M.
    Cappello, P.
    Roncalli, M.
    Zerbi, A.
    Montorsi, M.
    Novelli, F.
    Mantovani, A.
    Allavena, P.
    Malesci, A.
    Laghi, L.
    BRITISH JOURNAL OF CANCER, 2013, 109 (09) : 2424 - 2433
  • [39] Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in squamous cell carcinoma of the tongue: Markers of nerve invasion?
    Doumas S.
    Paterson J.C.
    Norris P.M.
    Tighe J.V.
    Newman L.
    Bisase B.S.
    Kolokotronis A.E.
    Barrett A.W.
    Oral and Maxillofacial Surgery, 2015, 19 (1) : 61 - 64
  • [40] Impact of chemokine receptor CX3CR1 in human renal allograft rejection
    Hoffmann, Ute
    Bergler, Tobias
    Segerer, Stephan
    Ruemmele, Petra
    Krueger, Bernd
    Banas, Miriam C.
    Reinhold, Stephan
    Banas, Bernhard
    Kraemer, Bernhard K.
    TRANSPLANT IMMUNOLOGY, 2010, 23 (04) : 204 - 208